Atrium Innovations (Atrium) is a globally recognised leader in the manufacturing, development and commercialisation of innovative, science-based health products. It has more than 2,000 health and nutrition products being sold through five primary brands. See how Permira is helping them grow the business…
Atrium Innovations
Why we backed them
- To grow their strong market position and help realise their potential to be a global industry megabrand
- To capitalise on the secular growth trends of an ageing population and an increasing focus on wellness and prevention versus treatment within this blossoming sub-sector
- To build on Atrium’s coveted industry position. It has the leading natural/independent health food store brand in the USA (Garden of Life) and a top-three standing in the North American healthcare practitioner channel (with the Pure, Douglas and Seroyal brands). The company also has a successful European business, based in Germany, under the Wobenzym banner
The investment strategy
- To utilise the opportunity to expand its product offering, brand awareness and points of distribution across the health food store, healthcare practitioner and European channels –as well as accelerating international growth
- To unlock it’s potential to make operational improvements and optimise margins by leveraging scale, investing in premium brands and by capitalising on the supply chain opportunities
- To evolve a decentralised, acquisition-led company into an organic growth leader backed by global operations and marketing expertise
- To achieve significant organic growth opportunities coupled with consolidation in this highly fragmented industry
The metrics
2014
Acquisition year
€754m
Transaction value
2017
Exit year